Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095020

Director acquired 500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Grissinger Michael · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-23 Grant or award : show line 1 in the form +500 799 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-23 Grant or award : show line 2 in the form Stock Options (Right to Buy) +2,000 2,000 D
Loading xslF345X05/tm2324788-7_4seq1.xml…